Allen Ho, MD, Otolaryngology (ENT), Los Angeles, CA, Cedars-Sinai Medical Center

AllenSzu-HaoHoMD

Otolaryngology (ENT) Los Angeles, CA

Head & Neck Oncologic Surgery

Associate Professor of Surgery

Dr. Ho is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ho's full profile

Already have an account?

Education & Training

  • Memorial Sloan-Kettering Cancer Center
    Memorial Sloan-Kettering Cancer CenterFellowship, Head and Neck Surgery, 2011 - 2014
  • Stanford University
    Stanford UniversityResidency, Otolaryngology, 2006 - 2011
  • Stanford University
    Stanford UniversityInternship, General Surgery, 2006 - 2007
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 2006
  • National Cancer Institute
    National Cancer InstitutePost-Doctoral Fellowship, 2003 - 2004
  • Harvard University
    Harvard UniversityBA, Neurobiology, 1996 - 2000

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2011 - Present
  • CA State Medical License
    CA State Medical License 2007 - 2023
  • American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
  • American Head and Neck SocietyHead and Neck Surgical Oncology

Awards, Honors, & Recognition

  • Super Doctors 2021
  • Castle Connolly Top Doctors 2021
  • Top Doctors 2020
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association of quantitative metastatic lymph node burden with survival in hypopharyngeal and laryngeal cancer  
    Ho AS, Kim S, Tighiouart M, Gudino C, Mita A, Scher KS, Laury A, Prasad R, Shiao SL, Ali N, Patio C, Mallen-St Clair J, Van Eyk JE, Zumsteg ZS, JAMA Oncology, 11/30/2017
  • Metastatic lymph node burden and survival in oral cavity cancer  
    Ho AS, Kim S, Tighiouart M, Gudino C, Mita A, Scher KS, Laury A, Prasad R, Shiao SL, Van Eyk JE, Zumsteg ZS, Journal of Clinical Oncology, 11/1/2017
  • Impact of Afirma gene expression classifier on cytopathology diagnosis and rate of thyroidectomy  
    Sacks WL, Bose S, Zumsteg ZS, Wong R, Shiao SL, Braunstein GD, Ho AS, Cancer, 10/1/2016
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Survival impact of treatment interval delays in head and neck cancer
    Ho AS, Kim S, Tighiouart M, Mita A, Scher K, Mallen-St. Clair J, Zumsteg ZS, ASTRO/ASCO/AHNS Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, AZ, 2/1/2018
  • Proteomic stratification of HPV(+) oropharyngeal squamous cell carcinoma identifies targets in insulin receptor signaling within nonresponders
    Robinson A, Laury A, Parker SJ, Shiao SL, Knudsen B, Zumsteg ZS, Van Eyk JE, Ho AS, AACR-AHNS Head and Neck Cancer Conference, San Diego, CA, 1/1/2017
  • Management trends in active surveillance of papillary thyroid microcarcinoma
    Sacks WL, Melany ML, Chen IE, Braunstein GD, Ho AS, American Thyroid Association (ATA) Annual Meeting, Denver, CO, 9/1/2016
  • Join now to see all

Lectures

  • Low-risk thyroid cancers 
    American Thyroid Association Annual Meeting, Victoria BC, Canada - 10/1/2017
  • The calibrated thyroid surgeon: how ATA has modernized thyroid cancer management 
    Thyroid Cancer Grand Rounds, Cedars-Sinai Medical Center, Los Angeles, CA - 9/1/2017
  • Anaplastic thyroid carcinoma: managment principles for an unprincipled disease 
    Advances in the Management of Thyroid Cancer Symposium, Los Angeles, CA - 10/1/2016
  • Join now to see all

Press Mentions

  • Head and Neck Cancer Treatment: The Right Timing Is Survival
    Head and Neck Cancer Treatment: The Right Timing Is SurvivalFebruary 6th, 2019
  • Treatment Delays May Mean Worse Survival in Head and Neck Cancer
    Treatment Delays May Mean Worse Survival in Head and Neck CancerOctober 16th, 2018
  • Number of Metastatic Lymph Nodes and Survival in Hypopharyngeal/Laryngeal Cancer
    Number of Metastatic Lymph Nodes and Survival in Hypopharyngeal/Laryngeal CancerMay 25th, 2018
  • Join now to see all

Grant Support

  • Adenoid Cystic Carcinoma Research Foundation GrantACCRF2013–Present
  • Young Investigator Research Development AwardAHNS/AAO-HNSF2012–Present
  • T32 Ruth Kirschstein National Research Service AwardNIH2011–Present
  • Continuing Support ScholarshipHHMI2004–2006

Committees

  • Member, ATA Development Committee 2016 - Present
  • Reviewer, AHNS CORE Study Section 2015 - Present

Professional Memberships

Other Languages

  • Chinese (Mandarin)

Hospital Affiliations